Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QUARTET-DKD: Quadruple Therapy in Type 2 Diabetic Kidney Disease
NCT07775846Phase 4Not yet recruiting
- Sponsor
- Huijie Zhang
- Start
- Sep 2026
- Primary completion
- Feb 2029
- Countries
- 1
01
Overview
A Phase 4 trial of finerenone, mazdutide in diabetic nephropathy (DKD), sponsored by Huijie Zhang. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
finerenonemazdutide
03
Conditions
diabetic nephropathy (DKD)
Beyond the preview
Go deeper on NCT07775846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07775846.